Cargando…

Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine

BACKGROUND: It has been estimated that approximately 15% of people who are incarcerated in the US have histories of opioid use disorder. Relapse to opioid use after release from prison poses a serious risk of HIV infection. Prison-initiated buprenorphine may help to reduce HIV infection given the as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blue, Thomas R., Gordon, Michael S., Schwartz, Robert P., Couvillion, Kathryn, Vocci, Frank J., Fitzgerald, Terrence T., O’Grady, Kevin E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886176/ https://www.ncbi.nlm.nih.gov/pubmed/31787108 http://dx.doi.org/10.1186/s13722-019-0172-2

Ejemplares similares

Improved HIV and Substance Abuse Treatment Outcomes for Released HIV-Infected Prisoners: The Impact of Buprenorphine Treatment
por: Springer, Sandra Ann, et al.
Publicado: (2010)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
por: Lund, Ingunn O., et al.
Publicado: (2013)

Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions
por: Sharma, Anjalee, et al.
Publicado: (2016)

Trends in Buprenorphine Use in US Jails and Prisons From 2016 to 2021
por: Thakrar, Ashish P., et al.
Publicado: (2021)

Detection of methadone and buprenorphine in urine samples from inmates of German prisons
por: Franchetti, Giorgia, et al.
Publicado: (2023)

Retention on Buprenorphine Is Associated with High Levels of Maximal Viral Suppression among HIV-Infected Opioid Dependent Released Prisoners
por: Springer, Sandra A., et al.
Publicado: (2012)

OUD Care Service Improvement with Prolonged-release Buprenorphine in Prisons: Cost Estimation Analysis
por: Wright, Nat, et al.
Publicado: (2020)

Comparing methadone and buprenorphine maintenance with methadone-assisted withdrawal for the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes
por: Lund, Ingunn O, et al.
Publicado: (2012)

Advancing emergency department–initiated buprenorphine
por: Huntley, Kristen, et al.
Publicado: (2021)

Improving Uptake of Emergency Department-initiated Buprenorphine: Barriers and Solutions
por: Kelly, Timothy D., et al.
Publicado: (2022)

Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials
por: Murphy, Sean M., et al.
Publicado: (2020)

Complaints: Mechanisms for prisoner participation?
por: Banwell-Moore, Rebecca, et al.
Publicado: (2022)

Emergency department‐initiated buprenorphine protocols: A national evaluation
por: Guo, Clara Z., et al.
Publicado: (2021)

Disparities in Emergency Department Naloxone and Buprenorphine Initiation
por: Papp, Joan, et al.
Publicado: (2023)

Emergency Department Use by Released Prisoners with HIV: An Observational Longitudinal Study
por: Meyer, Jaimie P., et al.
Publicado: (2012)

Implementation Facilitation to Promote Emergency Department–Initiated Buprenorphine for Opioid Use Disorder
por: D’Onofrio, Gail, et al.
Publicado: (2023)

Emergency-department initiated buprenorphine: Impact on quality of life
por: Carroll, Caleb, et al.
Publicado: (2023)

Barriers and Facilitators to Clinician Readiness to Provide Emergency Department–Initiated Buprenorphine
por: Hawk, Kathryn F., et al.
Publicado: (2020)

Buprenorphine Dosage and Urine Quantitative Buprenorphine, Norbuprenorphine, and Creatinine Levels in an Office-Based Opioid Treatment Program
por: Furo, Hiroko, et al.
Publicado: (2021)

Buprenorphine
por: Mazurek, Jaroslaw, et al.
Publicado: (2014)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Emergency physician perspectives on initiating buprenorphine/naloxone in the emergency department: A qualitative study
por: Dong, Kathryn A., et al.
Publicado: (2021)

Impact of Prison Status on HIV-Related Risk Behaviors
por: Hudson, Angela L., et al.
Publicado: (2009)

HIV and incarceration: prisons and detention
por: Jürgens, Ralf, et al.
Publicado: (2011)

Prison brain? Executive dysfunction in prisoners
por: Meijers, Jesse, et al.
Publicado: (2015)

Criminal charges prior to and after initiation of office-based buprenorphine treatment
por: Harris, Elizabeth E, et al.
Publicado: (2012)

Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic
por: Wang, Linda, et al.
Publicado: (2021)

Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19
por: Samuels, Elizabeth A., et al.
Publicado: (2022)

Incarceration status at buprenorphine initiation and OUD treatment outcomes during pregnancy
por: Nguyen, Andrea, et al.
Publicado: (2023)

Prevalence and predictors of suicidality among adults initiating office-based buprenorphine
por: Lent, Michelle R., et al.
Publicado: (2023)

The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) prisons project: a randomised controlled trial comparing dihydrocodeine and buprenorphine for opiate detoxification
por: Sheard, Laura, et al.
Publicado: (2009)

Moral foundations and decisions to donate bonus to charity: Data from paid online participants in the United States
por: O'Grady, Trevor, et al.
Publicado: (2019)

Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service
por: Nordeck, Courtney D., et al.
Publicado: (2022)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Buprenorphine Treatment Episodes During the First Year of COVID: a Retrospective Examination of Treatment Initiation and Retention
por: Stein, Bradley D., et al.
Publicado: (2022)

Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department–Initiated Buprenorphine Programs
por: Sue, Kimberly L., et al.
Publicado: (2023)

Rapid Identification of Buprenorphine in Patient Saliva
por: Farquharson, Stuart, et al.
Publicado: (2017)

No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy
por: Feng, Hwa‐Ping, et al.
Publicado: (2018)

Risk Factors for Interpersonal Violence in Prison: Evidence From Longitudinal Administrative Prison Data in Northern Ireland
por: Butler, Michelle, et al.
Publicado: (2021)

Correlates of HIV Stigma in prison guards and case workers in a national prison system
por: Albizu-García, Carmen E, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_o37p7c585ll1vojq491ju9071g